Clinical Insights: July 27, 2021
Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug Approval Bylvay™ (odevixibat) Capsules – New Drug Approval – July 20, 2021 – Albireo Pharma, Inc., a rare liver disease company developing novel bile acid modulators, announced the U.S. Food…
Clinical Insights: July 20, 2021
Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug Approval Rezurock™ (belumosudil) Tablets – New Drug Approval – July 16, 2021 – The Food and Drug Administration approved belumosudil (Rezurock™, Kadmon Pharmaceuticals, LLC), a kinase inhibitor, for adult and…
Clinical Insights: July 13, 2021
Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug Approval Padcev™ (enfortumab vedotin-ejfv) – New Drug Approval – July 9, 2021 – The Food and Drug Administration approved enfortumab vedotin-ejfv (Padcev™, Astellas Pharma US, Inc.), a Nectin-4-directed antibody…
Clinical Insights: July 6, 2021
Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug Approval Rylaze™ (asparaginase erwinia chrysanthemi (recombinant)-rywn) Injection – New Drug Approval – June 30, 2021 – Jazz Pharmaceuticals plc announced the U.S. Food and Drug Administration (FDA) approval of…
Clinical Insights: June 29, 2021
Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug Approval Verkazia™ (cyclosporine) Ophthalmic Emulsion – New Drug Approval – June 23, 2021 – Santen Pharmaceutical Co., Ltd announced that the U.S. Food and Drug Administration (FDA) has approved…
Clinical Insights: June 22, 2021
Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug Approval Rezipres® (ephedrine hydrochloride) Injection – New Drug Approval – June 15, 2021 – Eton Pharmaceuticals, Inc announced that the U.S. Food and Drug Administration (FDA) has approved Rezipres®…
Clinical Insights: June 15, 2021
Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug Approval Prevnar 20™ (pneumococcal 20-valent conjugate vaccine) Injection – New Vaccine Approval – June 8, 2021 – Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) has…
Clinical Insights: June 8, 2021
Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug Approval Tembexa™ (brincidofovir) – New Drug Approval – June 4, 2021 – The U.S. Food and Drug Administration approved Tembexa™ (brincidofovir) to treat smallpox. Although the World Health Organization declared…
Clinical Insights: June 1, 2021
Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug Approval Lumakras™ (sotorasib) – New Drug Approval – May 28, 2021 – The U.S. Food and Drug Administration approved Lumakras™ (sotorasib) as the first treatment for adult patients with…
Clinical Insights: May 25, 2021
Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug Approval Rybrevant™ (amivantamab-vmjw) Injection – New Drug Approval – May 21, 2021 – The U.S. Food and Drug Administration approved Rybrevant™ (amivantamab-vmjw) as the first treatment for adult patients with…
Clinical Insights: May 18, 2021
Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug Approval Empaveli™ (pegcetacoplan) Injection – New Drug Approval – May 14, 2021 – Apellis Pharmaceuticals, Inc., a global biopharmaceutical company and leader in targeted C3 therapies, announced that the U.S….
Clinical Insights: May 11, 2021
Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug Approval No new update. New Formulation Approval No new update. New Indication/Dosage Approval No new update. New/Updated Drug Shortage May 07, 2021 Azacitidine for Injection (Currently in Shortage) Bumetanide…